| 000 | 01722 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514035642.0 | ||
| 264 | 0 | _c20020910 | |
| 008 | 200209s 0 0 eng d | ||
| 022 | _a0333-1024 | ||
| 024 | 7 |
_a10.1046/j.1468-2982.2002.00358.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarbanti, P | |
| 245 | 0 | 0 |
_aUnilateral cranial autonomic symptoms in migraine. _h[electronic resource] |
| 260 |
_bCephalalgia : an international journal of headache _cMay 2002 |
||
| 300 |
_a256-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAfferent Pathways _xphysiopathology |
| 650 | 0 | 4 |
_aAnalgesics, Non-Narcotic _xpharmacology |
| 650 | 0 | 4 |
_aConjunctiva _xpathology |
| 650 | 0 | 4 |
_aEdema _xetiology |
| 650 | 0 | 4 |
_aEyelids _xpathology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperemia _xetiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMigraine Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aNasal Mucosa _xmetabolism |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xdrug effects |
| 650 | 0 | 4 | _aReceptor, Serotonin, 5-HT1B |
| 650 | 0 | 4 | _aReceptor, Serotonin, 5-HT1D |
| 650 | 0 | 4 |
_aReceptors, Serotonin _xdrug effects |
| 650 | 0 | 4 | _aReflex |
| 650 | 0 | 4 |
_aSerotonin Receptor Agonists _xpharmacology |
| 650 | 0 | 4 |
_aTears _xmetabolism |
| 650 | 0 | 4 |
_aTrigeminal Nerve _xphysiopathology |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
| 700 | 1 | _aFabbrini, G | |
| 700 | 1 | _aPesare, M | |
| 700 | 1 | _aVanacore, N | |
| 700 | 1 | _aCerbo, R | |
| 773 | 0 |
_tCephalalgia : an international journal of headache _gvol. 22 _gno. 4 _gp. 256-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1468-2982.2002.00358.x _zAvailable from publisher's website |
| 999 |
_c11993811 _d11993811 |
||